Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 1/20 | 0.58 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.52 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20991859 | 0.85 | BIRC2 (0.73) | BIRC2TET2RECQLCA1CA2 | |
| SCHEMBL21914636 | 0.85 | BIRC2 (0.73) | BIRC2TET2RECQLCA1CA2 | |
| SCHEMBL23235630 | 0.85 | BIRC2 (0.73) | BIRC2TET2RECQLCA1CA2 | |
| SCHEMBL23801208 | 0.82 | BIRC2 (0.64) | BIRC2TET2RECQLTSHRCA1 | |
| SCHEMBL4017322 | 0.79 | HDAC7 (0.56) | HDAC7HDAC8HDAC6HDAC9HDAC5 | |
| SCHEMBL13374821 | 0.79 | HDAC7 (0.56) | BIRC2HDAC7HDAC8HDAC6HDAC9 | |
| Valrocemide SCHEMBL4014030 | 0.78 | HDAC7 (0.54) | BIRC2HDAC7HDAC8HDAC6HDAC9 | |
| SCHEMBL10433522 | 0.77 | BIRC2 (0.44) | BIRC2HDAC7HDAC8HDAC6HDAC9 | |
| SCHEMBL7734253 | 0.77 | BIRC2 (0.44) | BIRC2TET2RECQL | |
| SCHEMBL26296395 | 0.76 | HDAC7 (0.62) | HDAC7HDAC8HDAC6HDAC9HDAC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100457720-C | 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine | YISSUM RES DEV CO (IL) | 2009-02-04 | — | — | CN | disclosed |
| CN-1418869-A | 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine | YISSUN RES DEV CO OF THE HEBRE (IL) | 2003-05-21 | — | — | CN | disclosed |
| CN-1106379-C | 2-propylvaleramide and 2-propylpentenamide derivatives and their use as anticonvulsants | YISSUM RES DEV CO (IL) | 2003-04-23 | — | — | CN | disclosed |
| EP-0659174-B1 | DERIVATIVES OF VALPROIC AND 2-VALPROENOIC ACID AMIDES AND USE AS ANTICONVULSANTS | YISSUM RES DEV CO (IL) | 1999-02-10 | — | — | EP | disclosed |
| US-5585358-A | ANTIEPILEPTIC AGENTS; COGNITION ACTIVATORS; NERVOUS SYSTEM DISORDERS; DYSKINESIA; ANTIISCHEMIC AGENTS | YISSUM RESEARCH DEVELOPMENT CORPORATION OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1996-12-17 | — | — | US | disclosed |
| CN-1111907-A | 2-propylvaleramide and 2-propylpentenamide derivatives and their use as anticonvulsants | YISSUM RES DEV CO (IL) | 1995-11-15 | — | — | CN | disclosed |
| EP-0659174-A4 | DERIVATIVES OF VALPROIC AND 2-VALPROENOIC ACID AMIDES AND USE AS ANTICONVULSANTS. | YISSUM RES DEV CO (IL) | 1995-09-27 | — | — | EP | disclosed |
| EP-0659174-A1 | DERIVATIVES OF VALPROIC AND 2-VALPROENOIC ACID AMIDES AND USE AS ANTICONVULSANTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1995-06-28 | — | — | EP | disclosed |
| WO-1995001956-A1 | DERIVATIVES OF VALPROIC AND 2-VALPROENOIC ACID AMIDES AND USE AS ANTICONVULSANTS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1995-01-19 | — | — | WO | disclosed |